跳至主要内容
临床试验/NCT03642288
NCT03642288Unknown不适用

The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction:A Retrospective Study

Jinling Hospital, China0 个研究点目标入组 112 人开始时间: 2014年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
发起方
入组人数
112
主要终点
The rate of successful conservative treatment

研究概览

简要总结

Chronic radiation enteropathy (CRE) is a major issue for long-term cancer survivors. The aim of this study was to clarify the diagnostic and therapeutic effect of the Gastrografin (GG) challenge for patients with CRE induced small bowel obstruction SBO.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • with a first diagnosis of CRE combined with SBO and ASBO that was determined by clinical history, computed tomography (CT) manifestation, and confirmed by intraoperative and histologic findings.
  • radiation therapy completed at least 6 months before enrolment.

排除标准

  • a colostomy or ileostomy;
  • large bowel obstruction;
  • with a known history of either allergy or hypersensitivity to iodinated contrast agents;
  • with signs of strangulation;
  • metastatic disease;
  • obstruction within 4 weeks after a recent operation or serious comorbidity.

研究组 & 干预措施

CRE-induced SBO

Experimental

Patients with CRE-induced SBO received GG challenge.

干预措施: Gastrografin (Drug)

ASBO

Active Comparator

Patients with adhesive SBO (ASBO) received GG challenge.

干预措施: Gastrografin (Drug)

结局指标

主要结局

The rate of successful conservative treatment

时间窗: 5 days

The rate of patients who need for operative intervention within 48 hours of randomization.

次要结局

  • The length of hospital stays(2 weeks)
  • The time to resolution(2 weeks)

研究者

发起方
Jinling Hospital, China
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ding Chao

Clinical Doctor

Jinling Hospital, China

相似试验

The Use of Gastrografin in Chronic Radiation... | 临床试验